These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 7026979)

  • 41. Bleeding patterns in postmenopausal women using continuous combination hormone replacement therapy with conjugated estrogen and medroxyprogesterone acetate or with 17beta-estradiol and norethindrone acetate.
    Odmark IS; Jonsson B; Bäckström T
    Am J Obstet Gynecol; 2001 May; 184(6):1131-8. PubMed ID: 11349178
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Trisequens.
    Drug Ther Bull; 1981 Jul; 19(16):63-4. PubMed ID: 7274066
    [No Abstract]   [Full Text] [Related]  

  • 43. Treatment of climacteric and postmenopausal women with 17-beta-oestradiol and norethisterone acetate.
    Furuhjelm M; Carlström K
    Acta Obstet Gynecol Scand; 1977; 56(4):351-61. PubMed ID: 602703
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Continuous combined conjugated equine estrogen-progestogen therapy: effects of medroxyprogesterone acetate and norethindrone acetate on bleeding patterns and endometrial histologic diagnosis.
    Hillard TC; Siddle NC; Whitehead MI; Fraser DI; Pryse-Davies J
    Am J Obstet Gynecol; 1992 Jul; 167(1):1-7. PubMed ID: 1442905
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Oestradiol: the predominant intranuclear oestrogen in the endometrium of oestrogen-treated postmenopausal women.
    Whitehead MI; Lane G; Dyer G; Townsend PT; Collins WP; King RJ
    Br J Obstet Gynaecol; 1981 Sep; 88(9):914-8. PubMed ID: 7272264
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Prospective perimenopausal estrogen-progestin substitution therapies for the prevention of osteoporosis].
    Dören M; Montag M; Schneider HP
    Arch Gynecol Obstet; 1989; 245(1-4):963-4. PubMed ID: 2529829
    [No Abstract]   [Full Text] [Related]  

  • 47. Effect of 1,25-dihydroxy-vitamin D3 in itself or combined with hormone treatment in preventing postmenopausal osteoporosis.
    Christiansen C; Christensen MS; Rødbro P; Hagen C; Transbøl I
    Eur J Clin Invest; 1981 Aug; 11(4):305-9. PubMed ID: 6795047
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Plasma oestrone, oestradiol and gonadotrophin concentrations in postmenopausal patients treated with oestradiol or with a combination of oestradiol and oestriol.
    Sipinen S
    Ann Clin Res; 1979 Oct; 11(5):172-8. PubMed ID: 121048
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Menopausal therapy and endometrial pathology.
    Craft I; Swinhoe J; Mugglestone CJ
    Br Med J; 1978 Aug; 2(6134):429-30. PubMed ID: 687955
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Transdermal hormonal replacement therapy with transdermal progestin every second month.
    Lindgren R; Risberg B; Hammar M; Berg G
    Maturitas; 1995 Jun; 22(1):25-30. PubMed ID: 7666813
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Does oestriol add to the beneficial effect of combined hormonal prophylaxis against early postmenopausal osteoporosis?
    Christiansen C; Rødbro P
    Br J Obstet Gynaecol; 1984 May; 91(5):489-93. PubMed ID: 6722065
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Serum placental protein 14 in pre-menopausal and post-menopausal women--dependency on oestrogen/progestogen status.
    Byrjalsen I; Riis BJ; Christiansen C
    Maturitas; 1990 Jun; 12(2):79-88. PubMed ID: 2255265
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Rationale for low-dose systemic hormone replacement therapy and review of estradiol 0.5 mg/NETA 0.1 mg.
    Johansen OE; Qvigstad E
    Adv Ther; 2008 Jun; 25(6):525-51. PubMed ID: 18568306
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Oestrogen concentrations in plasma, endometrium, myometrium and vagina of postmenopausal women, and effects of vaginal oestriol (E3) and oestradiol (E2) applications.
    van Haaften M; Donker GH; Haspels AA; Thijssen JH
    J Steroid Biochem; 1989 Oct; 33(4A):647-53. PubMed ID: 2811377
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Acceptability and patterns of endometrial bleeding in estradiol-based HRT regimens: a comparative study of cyclical sequential combinations of trimegestone or norethisterone acetate.
    al-Azzawi F; Wahab M; Thompson J; Pornel B; Hirvonen E; Ylikorkala O; van der Mooren MJ; Dillon J; Magaril C
    Climacteric; 2001 Dec; 4(4):343-54. PubMed ID: 11770191
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The endometrial status of women on long-term continuous combined hormone replacement therapy.
    Hawthorn RJ; Spowart K; Walsh D; Hart DM
    Br J Obstet Gynaecol; 1991 Sep; 98(9):939-40. PubMed ID: 1911615
    [No Abstract]   [Full Text] [Related]  

  • 57. The effects of continuous combined transdermal oestrogen-progestogen treatment on bleeding patterns and the endometrium in postmenopausal women.
    Oosterbaan HP; van Buuren AH; Schram JH; van Kempen PJ; Ubachs JM; van Leusden HA; Beyer GP
    Maturitas; 1995 Apr; 21(3):211-9. PubMed ID: 7616870
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Does calcium potentiate the bone-preserving effect of oestrogen treatment in early post-menopausal women by a change in vitamin D metabolism?
    Riis BJ; Christiansen C
    Maturitas; 1984 Jul; 6(1):65-70. PubMed ID: 6381968
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical and endometrial effects of oestradiol and progesterone in post-menopausal women.
    Darj E; Nilsson S; Axelsson O; Hellberg D
    Maturitas; 1991 Jun; 13(2):109-15. PubMed ID: 1921733
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of combined oral estrogen/progestogen preparation (Kliogest) on bone mineral density, plasma lipids and postmenopausal symptoms in HRT-naïve Thai women.
    Jirapinyo M; Theppisai U; Manonai J; Suchartwatnachai C; Jorgensen LN
    Acta Obstet Gynecol Scand; 2003 Sep; 82(9):857-66. PubMed ID: 12911449
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.